Unknown

Dataset Information

0

Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma.


ABSTRACT: Glioblastoma multiforme (GBM), a primary brain malignancy characterized by high morbidity, invasiveness, proliferation, relapse and mortality, is resistant to chemo- and radiotherapies and lacks effective treatment. GBM tumors undergo metabolic reprograming and develop anti-apoptotic defenses. We targeted GBM with a peptide derived from the mitochondrial protein voltage-dependent anion channel 1 (VDAC1), a key component of cell energy, metabolism and apoptosis regulation. VDAC1-based cell-penetrating peptides perturbed cell energy and metabolic homeostasis and induced apoptosis in several GBM and GBM-derived stem cell lines. We found that the peptides simultaneously attacked several oncogenic properties of human U-87MG cells introduced into sub-cutaneous xenograft mouse model, inhibiting tumor growth, invasion, and cellular metabolism, stemness and inducing apoptosis. Peptide-treated tumors showed decreased expression of all tested metabolism-related enzymes and transporters, and elevated levels of apoptotic proteins, such as p53, cytochrome c and caspases. Retro-Tf-D-LP4, containing the human transferrin receptor (TfR)-recognition sequence, crossed the blood-brain barrier (BBB) via the TfR that is highly expressed in the BBB to strongly inhibit tumor growth in an intracranial xenograft mouse model. In summary, the VDAC1-based peptides tested here offer a potentially affordable and innovative new conceptual therapeutic paradigm that might overcome GBM stemness and invasiveness and reduce relapse rates.

SUBMITTER: Shteinfer-Kuzmine A 

PROVIDER: S-EPMC5458211 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma.

Shteinfer-Kuzmine Anna A   Arif Tasleem T   Krelin Yakov Y   Tripathi Shambhoo Sharan SS   Paul Avijit A   Shoshan-Barmatz Varda V  

Oncotarget 20170501 19


Glioblastoma multiforme (GBM), a primary brain malignancy characterized by high morbidity, invasiveness, proliferation, relapse and mortality, is resistant to chemo- and radiotherapies and lacks effective treatment. GBM tumors undergo metabolic reprograming and develop anti-apoptotic defenses. We targeted GBM with a peptide derived from the mitochondrial protein voltage-dependent anion channel 1 (VDAC1), a key component of cell energy, metabolism and apoptosis regulation. VDAC1-based cell-penetr  ...[more]

Similar Datasets

| S-EPMC5570220 | biostudies-literature
| S-EPMC4039365 | biostudies-literature
| S-EPMC3789174 | biostudies-literature
| S-EPMC5994780 | biostudies-literature
| S-EPMC6026870 | biostudies-other
| S-EPMC3349966 | biostudies-literature
| S-EPMC6912264 | biostudies-literature
| S-EPMC6822236 | biostudies-literature
| S-EPMC5781317 | biostudies-literature
| S-EPMC5498802 | biostudies-literature